Currently, in the aftermath of the nuclear power reactor accident in Fukushima, the assessment of environmental and social risks associated with technological and natural uncertainties is thought

to be particularly important. Yet this type of assessment lies outside the scope of this study. Instead, we focus on the costs and mitigation potentials of low-carbon technologies.   3 Bioenergy supply is assumed to cause no major land use change or additional CO2 emission in any of the scenarios in this study. See “Key assumptions on the availability of resources and technologies” for more detail.   4 This is a rough approximation of the relationship between bioenergy supply and CO2 emission from land use change. More detailed analysis click here on bioenergy utilization and CO2 emission requires an integrated modeling approach on energy and land use. Yet this type of analysis https://www.selleckchem.com/products/lcz696.html remains to be done.   5 The nuclear power plant accident in Fukushima may increase scepticism about the safety of nuclear power plants and persuade some countries to scale down their nuclear policies. Some countries, in fact, have already announced plans to phase out their nuclear plants. Overall, however, the impact of the Fukushima nuclear accident over long-term nuclear policies around the world remains to be seen. Therefore, this

impact is not considered in this study. Paclitaxel molecular weight   6 AIM/Enduse[Global] includes integrated biomass gasification combined cycle (biomass IGCC) with CCS as an option for power generation. Biomass IGCC is a promising biomass power generation technology considered both highly efficient and economically feasible, as it is technically similar to the efficient coal IGCC process and can profit from the experiences gained with coal IGCC plants (Rhodes 2007). When biomass IGCC and CCS are integrated in a combined system, nearly all CO2 can be captured (Luckow et al. 2010). Yet biomass

IGCC is still in the demonstration phases: only a few demonstration plants have been built so far.”
“Transitions to cleaner, renewable energy are at the heart of policies in many countries. The focus on renewables has, if anything, become greater recently as uncertainty grows about the viability and acceptability of alternatives to achieve low-carbon growth, including nuclear power and carbon capture and YAP-TEAD Inhibitor 1 price storage (REN21 2010). The Fukushima accident has forced many governments to rethink their nuclear energy plans—Japan has just shutdown their last nuclear power plant, and Germany announced last year it will be nuclear free by 2022. But transitions away from fossil fuel-based energy systems have proven slow despite the potential of renewable energy sources and advancing technologies to utilize them.

The latter type of glycosylation predicted for the C-terminal protein parts occurs often at serine and threonine residues that would otherwise be phosphorylated; one illustration of the complex interplay among eukaryotic post-translational modification systems

[39]. N-glycosylation at N165/165 (site: NDS) and N296/298 (site: NFT) was predicted for Chi2/Chi3, respectively. These posttranslational modifications may account for the discrepant masses deduced from primary protein sequences and calculated on the basis of the electrophoretic mobility (Figure 1). Putative sites see more for C-linked glycosylation (C-mannosylation, [39]) were not found. The tripeptide ‘RGD’ mediating cell adhesion (R81 to D83) was predicted for Chi2. Potential sites for phosphorylation at serine, threonine and tyrosine residues are listed in the Additional file 4. Temporal mRNA expression analysis for CHI2 and CHI3 Next, we verified that target genes selected for the DNA-based diagnostic crayfish-plague assay are subject to

functional constraint. This could be assumed if temporal expression of target genes significantly changes during physiological conditions relevant to the infection in vivo. The CHI2 and CHI3 mRNA copy numbers expressed in the A. astaci mycelium, grown in chitin-free culture were quantified over three days at intervals RepSox of twelve hours using one-step qRT-PCR. A partial sequence of the nuclear gene NDUFV1 encoding the mitochondrial protein NADH dehydrogenase (ubiquinone) flavoprotein 1, which is part

of mitochondrial KU-57788 mouse respiratory chain complex I, was identified in this work (data not shown, GenBank:EU500726). We used this sequence as target for an endogenous positive control qRT-PCR assay reporting deviations in extraction, reverse transcription and PCR amplification including mRNA integrity, quality, and quantity. Gemcitabine Overall, levels of NDUFV1 mRNA changed only slightly across the time points studied (< 2.5-fold), including, however, expression changes which were near or below the level of significance (p = 0.05) but not matching the temporal expression patterns of the chitinases. In detail, the dynamic growth of the mycelium during the first hours in drop culture (12 to 24 hours, [18]) was reflected by the higher NDUFV1 expression found after 12 and 24 hours of culture (P = 0.03 and 0.07, respectively). Mycelium growth reached its plateau after 72 hours of incubation. The decreasing energy requirement and the beginning of autolytic processes at this stage are reflected by a lower NDUFV1-transcript copy number (P = 0.05 for expressions at 72 and 24 hours). The chitinase genes CHI2 and CHI3 were both constitutively expressed in mycelium grown in a medium lacking the substrate chitin. However, different mRNA amounts and temporal expression patterns, including the time point at which the maximum level was reached, were observed (Figure 4). Most prominent was the significant maximum in the CHI2 mRNA level reached after 48 hours (P = 0.013).

Sublingual https://www.selleckchem.com/products/AZD6244.html testosterone (0.5 mg) produces an increase in sexual motivation and desire in sexually functional women, about 4 hours after its peak plasma levels (time to maximum concentration [T max] = 15 min) PD0325901 manufacturer [9]. The testosterone and the PDE-5 inhibitor are released in such a timeframe that the peak plasma concentration of the PDE-5 inhibitor coincides with the 4-hour delay in behavioral effects of the testosterone. In women with low sensitivity to sexual cues,

this combination showed superiority over placebo in increasing sexual satisfaction [7, 10]. For women who have a dysfunctional activation of sexual inhibitory mechanisms during sexual stimulation, Lybridos is developed. 8-Bromo-cAMP price Lybridos is the combination of sublingual testosterone and a 5-HT1A receptor agonist (buspirone), released in such a timeframe that the pharmacological effects of the 5-HT1A receptor agonist coincide with the behavioral window induced by the testosterone administration

[8]. This combination in women with dysfunctional activation of sexual inhibitory mechanisms increased sexual satisfaction compared with placebo [8]. In previous clinical trials, the two components (sublingual testosterone in combination with a PDE-5 inhibitor or 5-HT1A receptor agonist) were administered separately; however, these components have been developed into one single combination tablet in recent phase IIb trials. Both products are intended for use on a ‘per need’ (i.e., not continuous or chronic) basis before anticipated sexual activity. Studies performed by various researchers have clearly indicated a time lag of about 3–4 hours in the pharmacodynamics effect of sublingual testosterone on genital arousal in women and other cognitive and affective functions [9, 11–23]. Therefore, either the PDE5 inhibitor (Lybrido) or (5-HT1a) receptor agonist (Lybridos) component needs to be administered approximately 2–3 hours after administering the

testosterone. In the above-mentioned clinical studies, this was obtained by administering the testosterone sublingually as a solution, followed 2.5 hours later by a PDE-5 inhibitor (sildenafil) or a 5-HT1A receptor agonist (buspirone) through as a tablet (to ensure blinding, the tablet was administered in a gelatin capsule), thus creating overlapping peaks in effect of testosterone and sildenafil or buspirone. Because this kind of administration is not suitable and rather cumbersome for daily use in practice, we developed a single oral combination tablet that will deliver testosterone sublingually and, approximately 2.5 hours later in the gastro-intestinal tract, the sildenafil or buspirone component, allowing women with FSIAD to take just one single tablet 3–6 hours before the anticipated sexual activity. The objective of this study was to see if the pharmacokinetic profile of testosterone given sublingually followed 2.

The refractive index effect is shown in Figure  4. As the refractive index increases, the surface resonance peak will red-shift and become increasingly sharp. Based on this, it is possible to predict the surface plasmon resonance peaks of regular

solution alloys, such as Au-Cu, Cu-Ag, Ag-Cu, and Au-Cu-Ag systems. Conclusion In this work we used the quasi-chemical model to compute the optical properties of Au-Cu alloy system. The results show that it is possible to use this approach to predict the positions of surface selleck screening library plasmon resonance peaks. This model is thus a useful tool in the development of for future applications of alloy nanoparticles for plasmonics and nanophotonics. Authors’ information YHS is an assistant professor and WLW is a student in the Department of Materials Science and Engineering in National Cheng Kung University, Taiwan. Acknowledgements This work was financially supported by the National Science Council of Taiwan (nos. 100-2218-E-259-003-MY3 and 102-2221-E-006-293-MY3) which is gratefully acknowledged. This research was, in part, supported by the Ministry of Education, Taiwan,

Republic of China I-BET-762 ic50 and the Aim for the Top University Project of the National Cheng Kung University (NCKU). References 1. Banholzer MJ, Osberg KD, Li S, Mangelson BF, Schatz GC, Mirkin CA: Silver-based nanodisk codes. ACS Nano 2010, 4:5446.CrossRef 2. Wustholz KL, Henry AI, McMahon JM, Freeman RG, Valley N, Piotti ME, Natan MJ, Schatz GC, Van Duyne RP: Structure-activity relationships in gold nanoparticle dimers and trimers for surface-enhanced Raman spectroscopy. J Am Chem Soc 2010, 132:10903.CrossRef 3. Zhang XL, Song JF, Li XB, Feng J, Sun HB Sun : Optical Tamm states enhanced broad-band absorption of organic solar cells. Appl Phys Lett 2012, 101:243901.CrossRef 4. Sen A, Lin CJ, Kaun CC: Single-molecule conductance through chiral gold

OSI-027 purchase nanotubes. J Phys Chem C 2013, 117:13676.CrossRef 5. Su YH, Ke YF, Cai SL, Yao QY: Surface plasmon resonance of layer-by-layer gold nanoparticles induced photoelectric current in environmentally-friendly plasmon-sensitized solar cell. Light Sci Appl Wilson disease protein 2012, 1:e14.CrossRef 6. Stratakis E, Kymakis E: Nanoparticle-based plasmonic organic photovoltaic devices. Mater Today 2013, 16:133.CrossRef 7. Su YH, Hsu CY, Chang CC, Tu SL, Shen YH: Ultra-thin titanium nanolayers for plasmon-assisted enhancement of bioluminescence of chloroplast in biological light emitting devices. Appl Phys Lett 2013, 103:063703.CrossRef 8. Cao YW, Jin R, Mirkin CA: DNA-modified core-shell Ag/Au nanoparticles. J Amer Chem Soc 2001, 123:7961.CrossRef 9. Nair AS, Suryannarayanan V, Pradeep T, Thomas J, Anija M, Philip R: AuxAgy@ZrO2 core – shell nanoparticles: synthesis, characterization, reactivity and optical limiting. Mater Sci Eng B 2005, 117:173.CrossRef 10.

Photos of three typical samples of GNP nanofluids at a concentration after 600 h are shown in Figure 1. Figure 1 Photo of GNP nanofluids after 600 h of storage selleck compound time. Analysis methods Detailed microstructures were further examined under a transmission electron microscope (TEM; TEM-LIBRA 120, Carl Zeiss, Oberkochen, Germany). The rheological behavior of the nanofluids of different weight percentage of graphene nanoplatelets was measured using an Anton Paar rheometer (Physica MCR 301, Anton Paar GmbH, Graz, Austria), which had recorded the viscosity and shear rate for different

temperatures. Electrical conductivity and zeta potential of the nanofluids were measured using Zetasizer Nano (Malvern Instruments Ltd., Malvern, UK). A transient heated needle (KD2 Pro, Decagon Devices, Inc., Pullman, WA, USA) was used to measure the see more thermal conductivity with 5% accuracy at constant temperature. The thermal conductivity measurements were repeated ten times, and the average values were reported.

Light transmission of all samples was measured with a Shimadzu UV spectrometer (UV-1800, Shimadzu Corporation, Kyoto, Japan) operating between 190 and 1,100 nm. The nanofluid solution was diluted with distilled water to allow sufficient transmission while each measurement was repeated three times to achieve a better accuracy. Results and discussion Morphology of GNP dispersions A drop of diluted solution was placed onto a carbon-coated copper grid, air-dried, and observed under TEM. Figure 2 shows the image of dried GNP suspensions with different specific surface areas. For the GNPs, the sheet-like learn more structure with a lateral size at the micrometer length scale has been well captured as shown

in Figure 2. Notably, the GNPs show good flexibility as proven by the folded and/or rolled parts. This indicates that each of the GNP sheets only contains a very limited number of graphene layers, which is consistent with the parameter provided by the manufacturer. When GNPs were dispersed by ultrasonic treatment, the lateral size of GNPs was decreased. The edges of GNP layers are clearly seen as straight lines. At higher specific surface area, the GNP size becomes smaller. The sonication process tends to break the flake: longer sonication time improves the exfoliation degree; further sonication is advantageous from N-acetylglucosamine-1-phosphate transferase the aspect of dispersion and colloidal stability. Figure 2 TEM images of GNP nanoparticles. (A) GNP 300, (B) GNP 500, and (C) GNP 750. Stability Stability investigation with UV–vis spectroscopy UV–vis spectrophotometer analysis is a convenient approach to characterize the stability of colloids quantitatively. Light absorbency ratio index can be calculated using the Beer Lambert law as shown in Equation 1: (1) Equation 1 shows that at fixed molar optical path and absorptivity, the absorbency is relative to the weight percentage of the particles inside the suspension.

CrossRef 4. Link S, EI-Sayed MA: Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver GSK461364 supplier nanodots and nanorods. J Phys Chem B 1999, 103:8410–8426.CrossRef 5. Jensen TR, Malinsky MD, Haynes CL, Van Duyne RP: Nanosphere lithography: tunable localized surface plasmon resonance spectra of silver nanoparticles. J Phys Chem B 2000, 104:10549–10556.CrossRef

6. Link S, EI-Sayed MA: Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int Rev Phys Chem 2000, 19:409–453.CrossRef 7. Haes AJ, Van Dutne RP: A nanoscale optical biosensor: sensitivity and selectivity of an approach based on the localized surface plasmon resonance spectroscopy of triangular silver nanoparticles. J Blebbistatin purchase Am Chem Soc 2002, 124:10596–10604.CrossRef 8. Haynes CL, McFarland AD, Zhao LL, Van Duyne RP, Schatez GC, Gunnarsson L, Prikulis J, selleckchem Kasemo B, Kall M: Nanoparticle optics: the importance of radiative

dipole coupling in two-dimensional nanoparticle arrays. J Phys Chem B 2003, 107:7337–7342.CrossRef 9. Richardson HH, Carlson MT, Tandler PJ, Hernandez P, Govorov AO: Experimental and theoretical studies of light-to-heat conversion and collective heating effects in metal nanoparticle solutions. Nano Lett 2009, 9:1139–1146.CrossRef 10. Kam W, O’Connell M, Wisdom JA, Dai H: Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell

destruction. Proc Natl Acad Sci USA 2005, 102:11600–11605.CrossRef 11. Ye E, Yin K, Tan HR, Lin M, Teng CP, Mlayah A, Han MY: Plasmonic gold nanocrosses with multidirectional excitation and strong photothermal effect. J Am Chem Soc 2011, 133:8506–8509.CrossRef 12. Welsher K, Liu Z, Sherlock SP, Robinson JT, Chen Z, Daranciang D, Dai H: A route to brightly fluorescent carbon nanotubes for near-infrared Aspartate imaging in mice. Nat Nanotechnol 2009, 4:773–780.CrossRef 13. Huang X, El-Sayed IH, Qian W, El-Sayed MA: Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006, 128:2115–2120.CrossRef 14. Huang HC, Barua S, Kay DB, Rege K: Simultaneous enhancement of photothermal stability and gene delivery efficacy of gold nanorods using polyelectrolytes. ACS Nano 2009, 3:2941–2952.CrossRef 15. Zhang Z, Wang L, Wang J, Jiang X, Li X, Hu Z, Ji Y, Wu X, Chen C: Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater 2012, 24:1418–1423.CrossRef 16. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL: Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 2003, 100:13549–13554.CrossRef 17.

A clinical study with oral squamous cell carcinomas shows that HLA class I expression is either weak or absent for not stimulation of CD8+ CTL, but there is still no a clear correlation of HLA class I expression loss with a relative proportion of NK cells, indicating that the local factors seem to down-regulate the final outcome of the cytotoxic immune response of NK cells [33]. https://www.selleckchem.com/products/ABT-888.html Indeed, reduced expression of natural cytotoxicity Salubrinal receptor, NKG2D ligand UL16 binding protein 1 and Inter-Cellular Adhesion Molecule 1 has been seen on tumor

cells [37, 38], which may specifically prevent NK cell activation. Non-classical HLA-G in inhibition of both CD8+ CTLs and NK cells HLA-G is a non-classical class I antigen, originally detected in trophoblastic cells [39], where it is proposed to suppress maternal immune response against the semi-allogeneic fetus. It binds to the inhibitory receptors Ig-like transcript (ILT) 2, ILT4 or KIR2DL4, resulting in suppression of cytotoxicity of both CD8+ CTL and NK cells [40, 41].

The protective role of HLA-G in carcinoma survival under immune surveillance is demonstrated in many studies with patients; in contrast to its null expression in normal epithelial cells and benign adenomas, a high percentage (30-90%) of carcinoma cells expresses HLA-G in a variety of cancerous lesions, and its levels C-X-C chemokine receptor type 7 (CXCR-7) have been found to be significantly associated with clinicopathological features and shorter survival time MCC950 concentration of patients [42–45]. All these data indicate that carcinoma-expressing HLA-G could be one of important mechanisms for inhibition of both CD8+CTL and NK cell mediated anti-carcinoma immunity. Induction of TIC apoptosis by expression of pro-apoptotic ligands Fas ligand (FasL) FasL binding to death receptor Fas triggers

apoptosis of Fas-expressing cells including TICs. Two patterns of FasL expression on carcinoma cells have been shown by immunohistochemical staining: (1) up-regulation of FasL expression on carcinoma is positively associated with clinicopathological features in patients, shown by that FasL expression is an early event in epithelial cell transformation (adenoma), followed by an increase in the percentage of FasL-expressing carcinoma cells in high-stage or -grade lesions, and the poorer survival of patients with high levels of FasL expression (Table 2); and (2) high levels of FasL expression have been seen as an independent factor for clinicopathological features, indicated by the positive staining of persistent FasL expression regardless of tumor stage, histologic grade, invasion and metastasis in many studies [47, 58–61]. All of these observations suggest that FasL expression is critical for carcinoma survival by induction of TIC apoptosis.

Stanley NR, Findlay K, Berks BC, Palmer T:Escherichia coli strains blocked in Tat-dependent protein export exhibit pleiotropic defects in the cell envelope. J Bacteriol 2001, 183:139–144.CrossRefPubMed 34. Chanal A, Santini CL, Wu L-F: Specific inhibition of the translocation of a subset of Escherichia coli TAT substrates by the

TorA signal peptide. J Mol Biol 2003, 327:563–570.CrossRefPubMed selleck inhibitor 35. Ali A, Johnson JA, Franco AA, Metzger DJ, Connell TD, Morris JG Jr, Sozhamannan S: Mutations in the extracellular protein secretion pathway genes ( eps ) interfere with rugose polysaccharide production in and motility of Vibrio cholerae. Infect Immun 2000, 68:1967–1974.CrossRefPubMed 36. Connell TD, Metzger DJ, Wang M, Jobling MG, Holmes RK: Initial studies

of the structural signal for extracellular transport of cholera toxin and other proteins recognized by Vibrio cholerae. Infect Immun 1995, 63:4091–4098.PubMed 37. Sandkvist M: Type II secretion and pathogenesis. Infect Immun 2001, 69:3523–3535.CrossRefPubMed 38. Zhu J, Mekalanos JJ: Quorum sensing-dependent biofilms enhance colonization in Vibrio cholerae. Dev Cell 2003, 5:647–656.CrossRefPubMed selleck compound 39. Ize B, Porcelli I, Lucchini S, Hinton JC, Berks BC, Palmer T: Novel Phenotypes of Escherichia coli tat mutants revealed by global gene expression and phenotypic analysis. J Biol Chem 2004, 279:47543–47554.CrossRefPubMed 40. Ghose AC: Adherence and colonization properties of Vibrio cholerae and diarrhoeagenic Escherichia coli. J Med Res Indian 1996, 104:38–51. 41. Heithoff DM, Mahan MJ:Vibrio cholerae biofilms: Stuck between a rock and a hard place. J Bacteriol 2004, 186:4835–4837.CrossRefPubMed 42. Sperandio V, Giron JA, Silveira WD, Kaper JB: The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae. Infect Immun 1995, 63:4433–4438.PubMed 43. Taylor RK: Bacterial adhesion to mucosal surfaces. J Chemother 1991, 3:190–195.PubMed 44. Posey JE, triclocarban Shinnick TM, Quinn FD: Characterization of the twin-arginine translocase secretion system of Mycobacterium smegmatis. J Bacteriol 2006, 188:1332–1340.CrossRefPubMed

45. Lipp EK, Huq A, Entospletinib manufacturer Colwell RR: Effects of global climate on infectious disease: the cholera model. Clin Microbiol Rev 2002, 15:757–770.CrossRefPubMed Authors’ contributions LZ and ZZ performed most of the experiments in this study. LZ confirmed the function of tatABC in V. cholerae. ZZ constructed some new deletion mutants, repeated and complemented the data of the experiments, and prepared the draft. HJ provided plasmids, performed TMAO experiments, and conceived the experiments. JZ performed reverse transcription-PCR and confocal microscopy. YX performed the complementation assay of the E. coli tat gene mutants with the tat genes of V. cholerae. MY taught molecular techniques, performed cell culture, and provided critical discussion about the methodology. SG and JX participated in the design and coordination of the study.

Further evidence that is consistent with this idea is the fact that for 30% of the iESTs, at least one EST sequenced from stress libraries corresponding to the same gene did not retain the intronic sequences, i.e., the corresponding mRNA was correctly processed (Additional file 1). The Entospletinib research buy spliceosome genes are not repressed under heat shock and cadmium stress The inhibition of mRNA splicing caused by heat shock and cadmium treatment could be due to a decrease in the expression of genes encoding

proteins of the spliceosome complex, leading to a reduction in the levels of the proteins forming the spliceosome. To test this hypothesis we identified all genes coding for spliceosome proteins that were present in B. emersonii EST database [19, 22, 23]. We observed 41 distinct genes (corresponding to 91 ESTs) encoding proteins involved in mRNA processing in this fungus (Additional file 2). To verify if these genes were up- or down-regulated during stress, we used the expression profile YH25448 nmr data of microarray assays of B. emersonii cells submitted to cadmium and heat shock, previously published by our group [19]. Among the 41 genes of B. emersonii related to mRNA processing, 29 were present on the microarray slide and only two of them were shown to be differentially expressed in response to cadmium or heat shock. One was induced

by heat shock (BeE60H22E01 – snRNP core protein SMX5d) and the other (BeE60N15H01 – putative small nuclear ribonucleoprotein Sm-D1) was repressed by cadmium treatment [19, 23]. The 41 genes observed through our search certainly

do not correspond to all genes involved in mRNA processing in B. emersonii, since it has been shown that the spliceosome machinery is formed by hundreds of proteins in eukaryotes [2]. Cyclooxygenase (COX) However, we believe that our set of genes is a significant part of those that encode proteins of the mRNA processing complex in B. emersonii. Nevertheless, we observed that only one gene was repressed under stress conditions. Thus, our data PARP inhibitor suggest that inhibition of mRNA splicing after cadmium and heat stress in this fungus is not due to a global repression of the genes involved in the splicing process under these conditions. One of the possible effects of cadmium that lead to toxicity in cells is its capacity of displace zinc (Zn2+) and calcium (Ca2+) from proteins that need these cations to perform their functions [16, 34, 35]. So, the inhibition of splicing by cadmium in B. emersonii could be due to the substitution of zinc in proteins involved in mRNA processing, which could lead to impairment or even to loss of their function. Considering this hypothesis, we evaluated if among B. emersonii spliceosome proteins there were some that possessed zinc-binding domains, as zinc finger or zinc-related motifs, which could be affected by the presence of cadmium inside the cells.

Proc Natl Acad Sci USA 2004,101(39):14240–14245.PubMedCrossRef 20. Arun S, Neubauer H, Gurel A, Ayyildiz G, Kuscu B, Yesildere T, Meyer H, Hermanns W: Equine glanders in Turkey. Vet Rec 1999,144(10):255–258.PubMedCrossRef 21. Neubauer H, Meyer H, Finke EJ: Human glanders. Revue Internationale des Services de Sante des Forces Armees 1997, 70:258–265. 22. Whitlock GC, Estes DM, Torres AG: Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett 2007,277(2):115–122.PubMedCrossRef

23. Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, Spacek L, Bartlett JG, Byrne WR, Thomas DL: Glanders in a military research microbiologist. N Engl J Med 2001,345(4):256–258.PubMedCrossRef 24. Gregory BC, Waag DM: Glanders. In Medical Aspects of Biological MAPK inhibitor Warfare. U.S Army Medical Department Borden Insitute Textbooks of Biological Warfare; 2007:121–146. 25. Waag DM, Deshazer D: Glanders: New insights into an old disease. In Biological Weapons Defense: Infectious Diseases and Counterbioterrorism. Edited by: Lindler LE LF,

Korch GW. Totowa, New Jersey: Humana Press Inc; 2004. 26. Nierman WC, DeShazer D, Kim HS, Tettelin H, Nelson KE, Feldblyum selleck compound T, Ulrich RL, Ronning CM, Brinkac LM, Daugherty SC, Davidsen TD, Deboy RT, Dimitrov G, Dodson RJ, Durkin AS, Gwinn ML, Haft DH, Khouri H, Kolonay JF, Madupu R, Mohammoud Y, Nelson WC, Radune D, Romero CM, Sarria S, Selengut J, Shamblin C, Sullivan SA, White O, Yu Y, Zafar N, Zhou L, Fraser CM: Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci USA 2004,101(39):14246–14251.PubMedCrossRef 27. Kumar A, Chua KL, Schweizer HP: Method for regulated expression of single-copy efflux pump

genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b. Antimicrob Agents Chemother 2006,50(10):3460–3463.PubMedCrossRef 28. Harland DN, Dassa E, Titball RW, Brown KA, Atkins HS: ATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia mallei. BMC Genomics 2007, 8:83.PubMedCrossRef Glycogen branching enzyme 29. Tribuddharat C, Moore RA, Baker P, Woods DE: Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition. Antimicrob Agents Chemother 2003,47(7):2082–2087.PubMedCrossRef 30. Dance DA, selleck kinase inhibitor Wuthiekanun V, Chaowagul W, White NJ: The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 1989,24(3):295–309.PubMedCrossRef 31. Jenney AW, Lum G, Fisher DA, Currie BJ: Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents 2001,17(2):109–113.PubMedCrossRef 32.